Literature DB >> 7725533

Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

S Takaya1, H Doyle, S Todo, W Irish, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7725533      PMCID： PMC2975964     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  44 in total

1.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

2.  Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

Authors:  S Takaya; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

3.  Clinicopathological study of livers from brain-dead patients treated with a combination of vasopressin and epinephrine.

Authors:  T Nagareda; Y Kinoshita; A Tanaka; Y Hasuike; N Terada; Y Nishizawa; M Q Fujita; H Kuroda; K Yawata; K Aozasa
Journal:  Transplantation       Date:  1989-05       Impact factor: 4.939

4.  The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model.

Authors:  Y Mizoguchi; H Tsutsui; K Miyajima; Y Sakagami; S Seki; K Kobayashi; S Yamamoto; S Morisawa
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

5.  Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure.

Authors:  A Francavilla; A Azzarone; G Carrieri; U Cillo; D Van Thiel; V Subbottin; T E Starzl
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

6.  A flexible procedure for multiple cadaveric organ procurement.

Authors:  T E Starzl; T R Hakala; B W Shaw; R L Hardesty; T J Rosenthal; B P Griffith; S Iwatsuki; H T Bahnson
Journal:  Surg Gynecol Obstet       Date:  1984-03

7.  Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution.

Authors:  N V Jamieson; R Sundberg; S Lindell; K Claesson; J Moen; P K Vreugdenhil; D G Wight; J H Southard; F O Belzer
Journal:  Transplantation       Date:  1988-10       Impact factor: 4.939

8.  Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys.

Authors:  Thomas E Starzl; Anthony J Demetris; Satoru Todo; Yoogoo Kang; Andreas Tzakis; Rene Duquesnoy; Leonard Makowka; Barbara Banner; Waldo Concepcion; Kendrick A Porter
Journal:  Clin Transplant       Date:  1989       Impact factor: 2.863

9.  The immunosuppressive properties of new oral prostaglandin E1 analogs.

Authors:  R Pollak; L J Dumble; J C Wiederkehr; M S Maddux; M Moran
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

Review 10.  Donor treatment after pronouncement of brain death: a neglected intensive care problem.

Authors:  R M Wijnen; C J van der Linden
Journal:  Transpl Int       Date:  1991-09       Impact factor: 3.782
View more
  5 in total

1.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

2.  Role of splenectomy in human liver transplantation under modern-day immunosuppression.

Authors:  F Samimi; W D Irish; B Eghtesad; A J Demetris; T E Starzl; J J Fung
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

Review 3.  Methods to decrease blood loss and transfusion requirements for liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Theodora Pissanou; Hynek Pikhart; Jessica Vaughan; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

4.  Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial.

Authors:  Behrouz Khajeh; Simin Dashti-Khavidaki; Mohsen Nasiri-Toosi; Keyhan Mohammadi; Atefeh Jafari
Journal:  Res Pharm Sci       Date:  2019-12-11

5.  Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis.

Authors:  James E Stahl; Jennifer E Kreke; Fawaz Ali Abdul Malek; Andrew J Schaefer; Joseph Vacanti
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.